Easywell Biomedicals (ROCO:1799) Long-Term Capital Lease Obligation : NT$349.7 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Long-Term Capital Lease Obligation?

Easywell Biomedicals's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$349.7 Mil.

Easywell Biomedicals's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (NT$348.4 Mil) to Dec. 2023 (NT$330.4 Mil) but then increased from Dec. 2023 (NT$330.4 Mil) to Mar. 2024 (NT$349.7 Mil).

Easywell Biomedicals's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (NT$315.6 Mil) to Dec. 2022 (NT$338.5 Mil) but then declined from Dec. 2022 (NT$338.5 Mil) to Dec. 2023 (NT$330.4 Mil).

Easywell Biomedicals Long-Term Capital Lease Obligation Historical Data

The historical data trend for Easywell Biomedicals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Long-Term Capital Lease Obligation Chart

Easywell Biomedicals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

314.52

288.89

315.64

338.48

330.45

Easywell Biomedicals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															335.07	339.24	348.44	330.45	349.67

Easywell Biomedicals (ROCO:1799) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Easywell Biomedicals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Easywell Biomedicals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Easywell Biomedicals (ROCO:1799) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.10, Yanfa 2nd Rd, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076

Website

http://www.easywellbio.com/en/index.php

Easywell Biomedicals Inc is engaged in the design, manufacture, and sales of thermometers for measuring body temperature and other medical instruments such as digital clinical thermometers, infrared ear thermometers, probe covers, and blood/urine/total cholesterol metabolites monitoring systems, among others. It has a Drug development segment and Other segments.

Easywell Biomedicals (ROCO:1799) Headlines

No Headlines